BMJ Retracts PREVENT-TAHA8 Stem Cell Heart Failure Trial
The BMJ has retracted the PREVENT-TAHA8 phase 3 trial on mesenchymal stem cells for heart failure due to data integrity and enrollment concerns.
By James Liu
Heart Failure
2 articles tagged "Heart Failure"
Updated NICE Guidance: Chronic Heart Failure in Adults
NICE updates chronic heart failure guidance, covering pharmacological optimisation across ejection fraction subtypes and IV iron supplementation recommendations.